By Chardelle Prevatt On Monday, September 19, 2016, GlycoNet scientists joined an elite group of industry experts in Montréal to discuss glycomics and oncology (glyco-oncology). Featuring Dr. Greg Plowman, VP (oncology research) at Eli Lilly and Company; Dr. Fred Sweeney, VP (business development and strategic alliances) at bioMerieux; and Dr. Luc Marengere, Managing Partner of TVM Capital Life Science, the panel offered invaluable […]
Catégorie : Network News
A multidisciplinary team of GlycoNet investigators is making strides towards taking down drug-resistant bacteria By Alexandria Daum A bacterial or fungal infection is difficult enough to treat, but when these infections form protective biofilms, it makes them even more stubborn. Now, the solution being explored by GlycoNet scientists is to prevent the biofilm from forming […]
Potential applications for Gaucher disease and Tay-Sachs disease By Alexandria Daum Every protein in a cell is sorted in the endoplasmic reticulum before it moves to other parts of the cell – think of it as a mailroom for proteins. If a piece of mail is missing an address, it’s thrown in the garbage. The […]
By Chardelle Prevatt On September 19, GlycoNet scientists will join industry leaders in Montreal to debate the current and future state of glycomics and oncology research. Panel discussions will focus on providing industry feedback and translating network research into tangible, commercial advances. The event will showcase some of the most notable voices in Canadian glycomics […]
By Chardelle Prevatt The Canadian Glycomics Network (GlycoNet) is delighted to announce the strengthening of its collaboration with Alberta Innovates Technology Futures (AITF). GlycoNet has recently received an extensive library of carbohydrate compounds from AITF. “We are excited to accept the contribution as part of AITF’s ongoing commitment to our glycomics research,” said Elizabeth Nanak, […]
Two new studies led by U of G researchers showing novel ways used by pathogens to make and attach protective cell coats might open a route to new drugs for penetrating those defences and treating often-serious infections.
GlycoNet Network Investigator Dr. Lynne Howell and her team at The Hospital for Sick Children are developing new methods to break down the wall that protects bacteria against current therapeutic interventions.
Carbohydrate synthesis, glycan structure analysis, and library screening are the core services being offered by GlycoNet, in partnership with the Alberta Glycomics Centre.
Partnership with CMO will allow GlycoNet researchers to work with a greater selection of oligosaccharides
A summary of GlycoNet Network Investigators Eric Brown and Gerard Wright’s recently published work “Antibacterial drug discovery in the resistance era”